{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:54Z","timestamp":1790542674038,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101332"],"award-info":[{"award-number":["82101332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32539","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T02:39:09Z","timestamp":1717641549000},"page":"e32539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neuromyelitis optica spectrum disorder with acute brainstem manifestations as initial symptoms"],"prefix":"10.1016","volume":"10","author":[{"given":"Zhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9762-2687","authenticated-orcid":false,"given":"Qi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e32539_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32539_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International con- sensus diagnostic criteria for neuromyelitis opti, ca spectrum disor- ders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32539_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/biomedicines7020042","article-title":"Neuromyelitis optica spectrum disorder and anti-MOG syndromes","volume":"7","author":"Lana-Peixoto","year":"2019","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32539_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1352458511404917","article-title":"Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder","volume":"17","author":"Kim","year":"2011","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32539_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12883-021-02059-1","article-title":"Neuromyelitis optica spectrum disorders with non opticospinal manifestations as initial symptoms: a long-term observational study","volume":"21","author":"Li","year":"2021","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32539_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jocn.2010.12.052","article-title":"Prominent brainstem symptoms\/signs in patients with neuromyelitis optica in a Taiwanese population","volume":"18","author":"Wang","year":"2011","journal-title":"J. Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32539_bib7","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32539_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2024.e32539_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.msard.2017.11.004","article-title":"Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: a cohort of Latin American patients","volume":"19","author":"Carnero","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32539_bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-014-7298-7","article-title":"Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions","volume":"261","author":"Wang","year":"2014","journal-title":"J. Neurol."},{"issue":"22","key":"10.1016\/j.heliyon.2024.e32539_bib11","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32539_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00415-020-09716-4","article-title":"The clinical profile of NMOSD in Australia and New Zealand","volume":"267","author":"Bukhari","year":"2020","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32539_bib13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32539_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3171\/2014.11.JNS14482","article-title":"The human area postrema: clear-cut silhouette and variations shown in vivo","volume":"122","author":"Longatti","year":"2015","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32539_bib15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/bpa.12087","article-title":"Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status","volume":"23","author":"Lana-Peixoto","year":"2013","journal-title":"Brain Pathol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32539_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/1352458513507822","article-title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","volume":"20","author":"Kremer","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.heliyon.2024.e32539_bib17","doi-asserted-by":"crossref","unstructured":"Banks S.A., Morris P.P., Chen J.J., et al., Brainstem and cerebellar involvement in MOG-IgG -associated disorder versus aquaporin-4-IgG and MS, J. Neurol. Neurosurg. Psychiatry. jnnp-2020-325121.","DOI":"10.1136\/jnnp-2020-325121"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32539_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12883-016-0721-1","article-title":"The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica","volume":"16","author":"Cheng","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.heliyon.2024.e32539_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102150","article-title":"Dorsal midbrain involvement in MRI as a core clinical manifestation for NMOSD diagnosis","volume":"43","author":"Etemadifar","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32539_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ncl.2010.03.006","article-title":"Eye movement abnormalities in multiple sclerosis","volume":"28","author":"Prasad","year":"2010","journal-title":"Neurol. Clin."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32539_bib21","first-page":"e33","article-title":"Teaching neuroimages: neuromyelitis optica misdiagnosed as spinal cord tumor","volume":"82","author":"Tsivgoulis","year":"201428","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32539_bib22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32539_bib23","first-page":"295","article-title":"Neuromyelitis optica--complication or comorbidity in primary Sj\u00f6gren's syndrome?","volume":"49","author":"Nitescu","year":"2011","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e32539_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103030","article-title":"The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: a systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32539_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaneurol.2016.5441","article-title":"Association of extension of cervical cord lesion and area postrema syndrome with neuromyelitis optica spectrum disorder","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32539_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32539_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12883-021-02171-2","article-title":"Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD","volume":"21","author":"Hsu","year":"2021","journal-title":"BMC Neurol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024085700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024085700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:37:20Z","timestamp":1790541440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024085700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024085700"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32539","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromyelitis optica spectrum disorder with acute brainstem manifestations as initial symptoms","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32539"}}